The FDA has approved zolbetuximab-clzb (VYLOY) as a first-line targeted therapy, in combination with chemotherapy, for the ...

Sanofi and Orano Med have partnered to accelerate the development of next-generation radioligand therapies for rare cancers, ...

Developed by AI, Lantern Pharma's investigational drug LP-184 has received FDA Fast-Track Designation for glioblastoma.

The Merlin test (CP-GEP), a molecular diagnostic tool developed by SkylineDx, significantly reduces the need for sentinel ...

The FDA has approved Genentech’s Itovebi™ (inavolisib) as a targeted therapy for adults with advanced hormone ...

Bayer and MOMA Therapeutics have announced a new collaboration aimed at advancing precision cancer treatments. The ...

Antibody-drug conjugates (ADCs) represent a significant breakthrough in oncology, offering targeted treatments, for lung ...

ADCs are at the forefront of cancer treatment, providing targeted therapies with promising results for lung cancer. We have ...